Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl

In this podcast recorded in early August, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September issue of DTB. They discuss the editorial ( ) that highlights some of the challenges associated with NHS England's national medicines optimisation measures for Integrated Care Boards. They talk about the MHRA's recent safety alert on the risk of an interaction between tramadol and warfarin ( ), which was prompted by a coroner's prevention of future deaths report (summarised in a DTB article in March ). The main article reviews the evidence for icosapent ethyl for cardiovascular risk reduction ( ). Please

You can listen to Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl online on Radio and Podcast. Open the player on this page to stream the available audio.

Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl is an episode from DTB podcast by BMJ Group.

This episode is 22:48 long.

This episode was published on Sep 6, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DTB podcast when more episodes are available from the podcast feed.